Showing results (591-600 of 1,009) with videos related to

Sort By:
Pageof 101
Australian and New Zealand Journal of Medicine|December 1, 1996
Symptomatic human immunodeficiency virus (HIV) infection in Papua New GuineaR A Seaton, J P Wembri, P Armstrong, et al.
The Journal of Clinical Investigation|June 1, 1974
Incomplete relaxation between beats after myocardial hypoxia and ischemiaM L Weisfeldt, P Armstrong, H E Scully, et al.
Arzneimittel-Forschung|January 1, 1984
[2-(Guanidino)-anilides and related compounds. Synthesis and anthelmintic effect. 3. Anthelmintics]H Wollweber, H Kölling, E Niemers, et al.
Organic Letters|January 30, 2007
Total synthesis of thapsigargin, a potent SERCA pump inhibitorMatthew Ball, Stephen P Andrews, Frank Wierschem, et al.
International Journal of Pharmaceutics|June 20, 2020
The design and development of high drug loading amorphous solid dispersion for hot-melt extrusion platformYiwei Tian, Esther Jacobs, David S Jones, et al.
Clinical and Diagnostic Laboratory Immunology|February 10, 1998
Expression, structure, and location of epitopes of the major surface glycoprotein of Pneumocystis carinii f. sp. cariniiM J Linke, S M Sunkin, R P Andrews, et al.
The Journal of Rheumatology|April 1, 1988
Patient outcome following inpatient vs outpatient treatment of rheumatoid arthritisR B Anderson, R D Needleman, R A Gatter, et al.
Pathogens (Basel, Switzerland)|February 26, 2022
Bartonella henselae Recombinant Pap31 for the Diagnosis of Canine and Human BartonellosesPradeep Neupane, Ricardo G Maggi, Manoj Basnet, et al.
Ophthalmic Surgery|May 1, 1995
Corneal endothelial polymerization of histoacryl adhesive: a report of a new intraocular complicationG D Markowitz, S E Orlin, W C Frayer, et al.
Infection and Immunity|June 1, 1996
Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challengeG P Andrews, D G Heath, G W Anderson, et al.
Pageof 101